Medtronic plc — Director's Dealing 2017

Dec 29, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-12-19

Reporting Person: WHITE ROBERT JOHN (EVP & President MITG)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	42144	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$27.29	2020-11-30	Ordinary Shares (16817)		Direct
Stock Option (Right to Buy)	$29.52	2021-11-30	Ordinary Shares (36996)		Direct
Stock Option (Right to Buy)	$36.58	2022-12-02	Ordinary Shares (37209)		Direct
Stock Option (Right to Buy)	$47.00	2023-12-01	Ordinary Shares (30755)		Direct
Stock Option (Right to Buy)	$25.41	2020-06-30	Ordinary Shares (7995)		Direct
Stock Option (Right to Buy)	$78.00	2025-08-03	Ordinary Shares (23932)		Direct
Stock Option (Right to Buy)	$88.06	2026-08-01	Ordinary Shares (24226)		Direct
Stock Option (Right to Buy)	$83.97	2027-07-31	Ordinary Shares (30170)		Direct
Stock Option (Right to Buy)	$74.84	2025-01-27	Ordinary Shares (26724)		Direct
Stock Option (Right to Buy)	$78.50	2025-02-18	Ordinary Shares (76434)		Direct
Stock Option (Right to Buy)	$78.00	2025-08-03	Ordinary Shares (1283)		Direct
Stock Option (Right to Buy)	$88.06	2026-08-01	Ordinary Shares (1136)		Direct
Stock Option (Right to Buy)	$83.97	2027-07-31	Ordinary Shares (1191)		Direct

Footnotes

F1: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

F2: This option becomes exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018

F3: These options become exercisable at a rate of 50% on the first anniversary of the grant and 25% on the second and third anniversary.